 |
| Stefan Borgas | Chief Executive Officer |
|---|---|
| Uwe H. Böhlke | Chief Officer Human Resources / Corporate Services |
| Stephan Kutzer | COO Custom Manufacturing division |
| Harry Boot | COO Life Science Ingredients division |
| Lukas Utiger | COO Bioscience division |
| Toralf Haag | Chief Financial Officer |
Divisions
| Custom Manufacturing (formerly Exclusive Synthesis & Biopharmaceutcals) |
| Life Science Ingredients |
| Bioscience |
Group Functions
| Global HR / Corporate Services | Legal | Corporate Development | Corporate Communications | Formulated Products |
| Key figures (million CHF) | 2009 | 2009 | 2010 |
|---|---|---|---|
| before special charges | after special charges 1 | ||
| Net sales | 2690 | 2690 | 2680 |
| Operating income | 380 | 239 | 374 |
| Net income | 279 | 159 | 284 |
| Cash flow before change in net working capital | 472 | 468 | 530 |
| Net debt | 1166 | 1166 | 1108 |
| Investments in property, plant and equipment | 511* | 511* | 300 |
| Number of employees | 8386 | 8386 | 8280 |
|
*excluding customer financial 1Special charges: - Impairment of assets (83) - Write-down of inventories (22) - Restructuring expenses (25) - Environmental expenses (11) - Total special charges (141) |
| Sales by operating segments (million CHF) | 2009 | 2010 |
|---|---|---|
| Custom Manufacturing | 1418 | 1445 |
| Life Science Ingredients | 1038 | 1020 |
| Bioscience | 231 | 211 |
| Corporate | 3 | 4 |
